{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:51:14Z","timestamp":1761101474532,"version":"build-2065373602"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Waldenstr\u00f6m macroglobulinemia (WM) is a slowly progressive hematologic malignancy that usually responds rapidly to treatment. Being a lymphoplasmacytoid neoplasm, it is associated with a monoclonal IgM component, which may be associated with multiple manifestations and symptoms. We report the case of a 77-year-old woman diagnosed with WM following the development of severe and sudden pancytopenia associated with a cold agglutinin syndrome. In order to treat the WM and the underlying hemolysis, treatment with rituximab, corticosteroids and cyclophosphamide was started. Despite the improvement in hemolysis parameters, pancytopenia persisted, and we started a second line with ibrutinib. During treatment the patient developed an uncommon invasive fungal infection (IFI) with bone marrow granulomatosis and myelofibrosis. This case shows an unusual clinical course with a poor hematopoietic response to treatment and a large number of intercurrent complications.<\/jats:p>","DOI":"10.3390\/biomedicines11041007","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T06:34:07Z","timestamp":1679639647000},"page":"1007","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenstr\u00f6m Macroglobulinemia in an Elderly Patient"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1798-9332","authenticated-orcid":false,"given":"Juan Carlos","family":"Caballero","sequence":"first","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Askari","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Carrasco","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-3634","authenticated-orcid":false,"given":"Miguel Angel","family":"Piris","sequence":"additional","affiliation":[{"name":"Pathology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Perez de Camino","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pardo","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0737-4211","authenticated-orcid":false,"given":"Javier","family":"Cornago","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-3902","authenticated-orcid":false,"given":"Jose Luis","family":"Lopez-Lorenzo","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Llamas","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8949-8762","authenticated-orcid":false,"given":"Laura","family":"Solan","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundacion Jimenez Diaz University Hospital, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom\u2019s macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom\u2019s Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41375-020-01102-3","article-title":"CXCR4 in Waldenstr\u00f6m\u2019s Macroglobulinema: Chances and challenges","volume":"35","author":"Kaiser","year":"2021","journal-title":"Leukemia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/bjh.13264","article-title":"Overall survival and competing risks of death in patients with Waldenstr\u00f6m macroglobulinaemia: An analysis of the Surveillance, Epidemiology and End Results database","volume":"169","author":"Castillo","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1038\/s41375-019-0431-y","article-title":"A revised international prognostic score system for Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"33","author":"Kastritis","year":"2019","journal-title":"Leukemia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.ctarc.2022.100527","article-title":"Current approach to Waldenstr\u00f6m Macroglobulinemia","volume":"31","author":"Ravi","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2147\/JBM.S267938","article-title":"Waldenstr\u00f6m\u2019s Macroglobulinemia: An Exploration into the Pathology and Diagnosis of a Complex B-Cell Malignancy","volume":"ume 12","author":"Askari","year":"2021","journal-title":"J. Blood Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/cid\/civ293","article-title":"Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031)","volume":"61","author":"Cornely","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood.2019000725","article-title":"How I treat Waldenstr\u00f6m macroglobulinemia","volume":"134","author":"Dimopoulos","year":"2019","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.20.00555","article-title":"Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstr\u00f6m Macroglobulinemia","volume":"39","author":"Treon","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12979-018-0130-y","article-title":"Immunosenescence and lymphomagenesis","volume":"15","author":"Mancuso","year":"2018","journal-title":"Immun. Ageing"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cger.2019.03.001","article-title":"Aging and Hematopoiesis","volume":"35","author":"Groarke","year":"2019","journal-title":"Clin. Geriatr. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstr\u00f6m macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMra2033982","article-title":"Autoimmune Hemolytic Anemias","volume":"385","author":"Berentsen","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100648","DOI":"10.1016\/j.blre.2019.100648","article-title":"Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting","volume":"41","author":"Barcellini","year":"2020","journal-title":"Blood Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0002-9343(82)90852-X","article-title":"B-Cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins)","volume":"72","author":"Crisp","year":"1982","journal-title":"Am. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3109\/10428190109097770","article-title":"Monotherapy with rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma","volume":"42","author":"Cohen","year":"2001","journal-title":"Leuk Lymphoma."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ajh.26082","article-title":"Waldenstr\u00f6m macroglobulinemia: 2021 update on diagnosis, risk stratification, and management","volume":"96","author":"Gertz","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/WCO.0b013e32832fd563","article-title":"Monoclonal gammopathy and neuropathy","volume":"22","author":"Ramchandren","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e2018004","DOI":"10.4084\/mjhid.2018.004","article-title":"Waldenstrom\u2019s Macroglobulinemia: An Update","volume":"10","author":"Mazzucchelli","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1177\/10781552211038309","article-title":"Bruton tyrosine kinase inhibitors for Waldenstr\u00f6m macroglobulinemia: A review","volume":"27","author":"Moore","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1501548","article-title":"Ibrutinib in Previously Treated Waldenstr\u00f6m\u2019s Macroglobulinemia","volume":"372","author":"Treon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.20452\/pamw.3578","article-title":"Ibrutinib-induced pyoderma gangrenosum","volume":"126","author":"Sobjanek","year":"2016","journal-title":"Pol. Arch. Med. Wewn."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/qjmed\/hcaa078","article-title":"Ulcerative colitis with refractory pyoderma gangrenosum","volume":"113","author":"Liu","year":"2020","journal-title":"QJM"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00277-014-2277-8","article-title":"Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorder","volume":"94","author":"Shah","year":"2015","journal-title":"Ann. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e00691","DOI":"10.1016\/j.idcr.2019.e00691","article-title":"Rapidly progressive necrotizing cellulitis secondary to Candida tropicalis infection in an immunocompromised host","volume":"19","author":"Krishnan","year":"2020","journal-title":"IDCases"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100635","DOI":"10.1016\/j.blre.2019.100635","article-title":"Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections","volume":"40","author":"Maffei","year":"2020","journal-title":"Blood Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/bjh.15627","article-title":"Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenstr\u00f6m macroglobulinaemia on ibrutinib","volume":"185","author":"Cheng","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmi.2017.08.016","article-title":"Acute disseminated candidiasis with skin lesions: A systematic review","volume":"24","author":"Guarana","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","article-title":"Candidemia and invasive candidiasis in adults: A narrative review","volume":"34","author":"Antinori","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.2147\/IDR.S274872","article-title":"Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches","volume":"14","author":"Tortorano","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5603\/ARM.a2017.0046","article-title":"Pulmonary Langerhans\u2019 cell histiocytosis in adults","volume":"85","author":"Radzikowska","year":"2017","journal-title":"Adv. Respir. Med."},{"key":"ref_34","first-page":"43","article-title":"IgG4-related disease","volume":"104","author":"Hirabayashi","year":"2012","journal-title":"Pathologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5152\/eurjrheum.2020.20076","article-title":"Bone marrow involvement: Atypical presentation of early-onset childhood sarcoidosis","volume":"7","author":"Meshram","year":"2020","journal-title":"Eur. J. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ijlh.12751","article-title":"Clinical and pathological feature of bone marrow granulomas: A modern Australian series","volume":"40","author":"Crispin","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.V11.8.720.720","article-title":"Granulomatous Lesions in Bone Marrow","volume":"11","author":"Pease","year":"1956","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3324\/haematol.2015.141283","article-title":"Bone marrow fibrosis in myelofibrosis: Pathogenesis, prognosis and targeted strategies","volume":"101","author":"Zahr","year":"2016","journal-title":"Haematologica"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2013-05-503862","article-title":"Primary therapy of Waldenstr\u00f6m macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): Long-term results of a phase 2 study of the European Myeloma Network (EMN)","volume":"122","author":"Dimopoulos","year":"2013","journal-title":"Blood"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1007\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:02:17Z","timestamp":1760122937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["biomedicines11041007"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11041007","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2023,3,24]]}}}